HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Exjade safely and effectively. See full prescribing information for Exjade. EXJADE® (deferasirox) tablets for oral

First Page		Document Content
Date: 2011-08-11 15:27:07 Phenols Antidotes Deferasirox Triazoles Myelodysplastic syndrome Creatinine Theophylline Beta-thalassemia Zileuton Chemistry Medicine Organic chemistry		HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Exjade safely and effectively. See full prescribing information for Exjade. EXJADE® (deferasirox) tablets for oral Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 170,36 KB Share Document on Facebook

	Marina Cavazzana [Mode de compatibilité] DocID: 1p4cO - View Document
	I would like to donate Name ............................................................................................... Diagnostic Lab Thalassemia & Sickle Cell Society Vuppala Krishna Rao & Chandrakala Diagnostic DocID: 1oVFa - View Document
	Sickle Cell Awareness Sickle Cell Disease (SCD) is an assembly of inherited red blood cell disorders. People with SCD have abnormal hemoglobin, termed as hemoglobin S or sickle hemoglobin, in their red blood cells. Inhe DocID: 1onjc - View Document
	Beta Thalassemia Genetic Testing Interpretation Order Form Patient´s name (first name, last name) DocID: 1crRW - View Document
	CORPORATE FACT SHEET December 2013 Acceleron is a biopharmaceutical company committed to discover, develop, manufacture and commercialize novel protein therapeutics for cancer and orphan diseases Acceleron’s scientific DocID: 19vEv - View Document